These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 2140395
1. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity. Rosenblum MG, Yung WK, Kelleher PJ, Ruzicka F, Steck PA, Borden EC. J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395 [Abstract] [Full Text] [Related]
2. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro. Ruzicka FJ, Schmid SM, Groveman DS, Cummings KB, Borden EC. Cancer Res; 1987 Sep 01; 47(17):4582-9. PubMed ID: 2957045 [Abstract] [Full Text] [Related]
3. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. Schiller JH, Horisberger MA, Bittner G, Carlin JM, Storer B, Byrne GI, Willson JK, Borden EC. J Biol Response Mod; 1990 Aug 01; 9(4):368-77. PubMed ID: 2395002 [Abstract] [Full Text] [Related]
4. Binding of human recombinant 125I-interferon gamma to receptors on human cells. Littman SJ, Faltynek CR, Baglioni C. J Biol Chem; 1985 Jan 25; 260(2):1191-5. PubMed ID: 3155725 [Abstract] [Full Text] [Related]
5. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures. Fraioli M, Wu JM. J Biol Regul Homeost Agents; 1989 Jan 25; 3(3):112-7. PubMed ID: 2624146 [Abstract] [Full Text] [Related]
6. Differential activity of the 30-kD and the 100-kD forms of 2'-5'An synthetase induced by recombinant human interferon-alpha and interferon-gamma. Rosenblum MG, Cheung L, Kessler D. J Interferon Res; 1988 Jun 25; 8(3):275-82. PubMed ID: 3137274 [Abstract] [Full Text] [Related]
7. Lectins modulate the internalization of recombinant interferon-alpha A and the induction of 2',5'-oligo(A) synthetase. Faltynek CR, Princler GL, Ruscetti FW, Birchenall-Sparks M. J Biol Chem; 1988 May 25; 263(15):7112-7. PubMed ID: 2966801 [Abstract] [Full Text] [Related]
8. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. Wietzerbin J, Gaudelet C, Aguet M, Falcoff E. J Immunol; 1986 Apr 01; 136(7):2451-5. PubMed ID: 2936825 [Abstract] [Full Text] [Related]
9. Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells. Yung WK, Steck PA, Kelleher PJ, Moser RP, Rosenblum MG. J Neurooncol; 1987 Apr 01; 5(4):323-30. PubMed ID: 2964515 [Abstract] [Full Text] [Related]
10. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells. Schiller JH, Bushmeyer SM, Ruzicka FJ, Princler GL, Faltynek CR, Borden EC. Cancer Res; 1990 Jan 01; 50(1):26-31. PubMed ID: 2136700 [Abstract] [Full Text] [Related]
11. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta. Yoshida R, Murray HW, Nathan CF. J Exp Med; 1988 Mar 01; 167(3):1171-85. PubMed ID: 2965208 [Abstract] [Full Text] [Related]
12. A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells. Faltynek CR, Princler GL, Gusella GL, Varesio L, Radzioch D. J Biol Chem; 1989 Aug 25; 264(24):14305-11. PubMed ID: 2474543 [Abstract] [Full Text] [Related]
13. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans. Schiller JH, Storer B, Paulnock DM, Brown RR, Datta SP, Witt PL, Borden EC. J Clin Invest; 1990 Oct 25; 86(4):1211-21. PubMed ID: 2120284 [Abstract] [Full Text] [Related]
14. Binding of unglycosylated and glycosylated human recombinant interferon-gamma to cellular receptors. Littman SJ, Devos R, Baglioni C. J Interferon Res; 1985 Oct 25; 5(3):471-6. PubMed ID: 2932505 [Abstract] [Full Text] [Related]
15. Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains. Ruzicka FJ, Jach ME, Borden EC. J Biol Chem; 1987 Nov 25; 262(33):16142-9. PubMed ID: 2960673 [Abstract] [Full Text] [Related]
16. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects. Rinehart JJ, Young D, Laforge J, Colborn D, Neidhart JA. Cancer Res; 1987 May 01; 47(9):2481-5. PubMed ID: 3567933 [Abstract] [Full Text] [Related]
17. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages. Witt PL, Spear GT, Helgeson DO, Lindstrom MJ, Smalley RV, Borden EC. J Interferon Res; 1990 Aug 01; 10(4):393-402. PubMed ID: 2121851 [Abstract] [Full Text] [Related]
18. Characterization of the human type I interferon receptor by ligand blotting. Schwabe M, Princler GL, Faltynek CR. Eur J Immunol; 1988 Dec 01; 18(12):2009-14. PubMed ID: 2975600 [Abstract] [Full Text] [Related]
19. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen. Goldstein D, Bushmeyer SM, Witt PL, Jordan VC, Borden EC. Cancer Res; 1989 May 15; 49(10):2698-702. PubMed ID: 2469536 [Abstract] [Full Text] [Related]
20. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase. Coccia EM, Federico M, Romeo G, Affabris E, Cofano F, Rossi GB. J Interferon Res; 1988 Feb 15; 8(1):113-27. PubMed ID: 2966842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]